Status:
UNKNOWN
Decortication With Calcium Phosphosilicate Putty in the Treatment of Non-contained Intrabony Periodontal Defects
Lead Sponsor:
Postgraduate Institute of Dental Sciences Rohtak
Conditions:
Periodontal Bone Loss
Eligibility:
All Genders
28-60 years
Phase:
NA
Brief Summary
To overcome the disadvantage of complex morphology and availability of less favorable support to retention of graft and clot stabilization in 1-, 1-2-wall periodontal defects, it was hypothesized that...
Detailed Description
The definite goal of periodontal regenerative therapy is to restore the tooth supporting tissues, lost as a result of inflammatory periodontal diseases and infections. Numerous treatment modalities ha...
Eligibility Criteria
Inclusion
- Patients with chronic periodontitis
- Presence of non- contained osseous defect
- Age 28 to 60 years (both males and females)
- Completed etiological periodontal therapy (oral hygiene instructions and scaling and root planing under local anaesthesia.
- At re-evaluation full mouth plaque score67 \< 1, full mouth bleeding score FMBS \<20%
- Non-smokers (Current and past smokers)
- Presence of ≥ 2mm of keratinized tissue to allow flap management
- Tooth defect criteria:
- Probing pocket depth ≥ 5mm
- Clinical attachment loss ≥ 5mm
- Associated with a 1-wall, 2-wall or a combined 1-2 wall osseous defect ≥ 3mm deep located in the interproximal area of single- and multirooted teeth (assessed by transgingival probing and radiograph, further to be confirmed after flap elevation)
- Tooth mobility ≤ 1
- Concerned tooth and adjoining teeth to be vital and without symptoms or signs of endodontic involvement
- Tooth and adjoining teeth free of caries or inadequate restorations/ unrestorable tooth.
- Absence of non-working interferences.
- Interproximal intrabony defects not extending into the furcation area of molar teeth.
Exclusion
- Medical conditions interfering with periodontal health or wound healing
- Systemic illness known to affect the periodontium or outcome of periodontal therapy.
- Patient taking medications such as corticosteroids or calcium channel blockers, which are known to interfere periodontal wound healing or patient on long term NSAID therapy.
- Patients allergic to medication (local anaesthetic, antibiotics, NSAID).
- Pregnant or lactating women.
- Fractured/perforated roots.
- Developing permanent tooth.
- History of recent periodontal treatment within 6 months prior to study.
- 3-wall intrabony defects
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2019
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03435757
Start Date
December 1 2017
End Date
April 1 2019
Last Update
February 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shikha Tewari
Rohtak, Haryana, India, 124001